Costs and outcomes of recombinant human bone morphogenetic protein-2 (rhBMP-2) usage in single level posterior or transforaminal lumbar interbody fusion (TLIF) in a propensity score matched national, retrospective cohort

Austin R. Chen, Jacob W. McDevitt, Parth N. Desai, Cade F. Bennett, A. Trice Pickens, Theodore A. Joaquin, Kranti C. Rumalla, Mark A. Plantz, Tyler M. Compton, Aaron K. Hoyt, Matthew W. Colman, Wellington K. Hsu, Alpesh A. Patel, Srikanth N. Divi

Open source

DOI
10.1016/j.spinee.2026.09.007
Published
2026-09
Container
The Spine Journal
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.spinee.2026.09.007,
  title = {Costs and outcomes of recombinant human bone morphogenetic protein-2 (rhBMP-2) usage in single level posterior or transforaminal lumbar interbody fusion (TLIF) in a propensity score matched national, retrospective cohort},
  author = {Austin R. Chen and Jacob W. McDevitt and Parth N. Desai and Cade F. Bennett and A. Trice Pickens and Theodore A. Joaquin and Kranti C. Rumalla and Mark A. Plantz and Tyler M. Compton and Aaron K. Hoyt and Matthew W. Colman and Wellington K. Hsu and Alpesh A. Patel and Srikanth N. Divi},
  year = {2026},
  journal = {The Spine Journal},
  doi = {10.1016/j.spinee.2026.09.007},
  url = {https://doi.org/10.1016/j.spinee.2026.09.007}
}

RIS

TY  - JOUR
TI  - Costs and outcomes of recombinant human bone morphogenetic protein-2 (rhBMP-2) usage in single level posterior or transforaminal lumbar interbody fusion (TLIF) in a propensity score matched national, retrospective cohort
AU  - Austin R. Chen
AU  - Jacob W. McDevitt
AU  - Parth N. Desai
AU  - Cade F. Bennett
AU  - A. Trice Pickens
AU  - Theodore A. Joaquin
AU  - Kranti C. Rumalla
AU  - Mark A. Plantz
AU  - Tyler M. Compton
AU  - Aaron K. Hoyt
AU  - Matthew W. Colman
AU  - Wellington K. Hsu
AU  - Alpesh A. Patel
AU  - Srikanth N. Divi
PY  - 2026
JO  - The Spine Journal
DO  - 10.1016/j.spinee.2026.09.007
UR  - https://doi.org/10.1016/j.spinee.2026.09.007
ER  - 

APA

Chen, A. R., McDevitt, J. W., Desai, P. N., Bennett, C. F., Pickens, A. T., Joaquin, T. A., Rumalla, K. C., Plantz, M. A., Compton, T. M., Hoyt, A. K., Colman, M. W., Hsu, W. K., Patel, A. A., & Divi, S. N. (2026). Costs and outcomes of recombinant human bone morphogenetic protein-2 (rhBMP-2) usage in single level posterior or transforaminal lumbar interbody fusion (TLIF) in a propensity score matched national, retrospective cohort. The Spine Journal. https://doi.org/10.1016/j.spinee.2026.09.007

Source records